134 related articles for article (PubMed ID: 38042020)
1. Leiomyoma or sarcoma? MRI performance in the differential diagnosis of sonographically suspicious uterine masses.
Valletta R; Corato V; Lombardo F; Avesani G; Negri G; Steinkasserer M; Tagliaferri T; Bonatti M
Eur J Radiol; 2024 Jan; 170():111217. PubMed ID: 38042020
[TBL] [Abstract][Full Text] [Related]
2. Investigating the diagnostic value of quantitative parameters based on T2-weighted and contrast-enhanced MRI with psoas muscle and outer myometrium as internal references for differentiating uterine sarcomas from leiomyomas at 3T MRI.
Malek M; Rahmani M; Seyyed Ebrahimi SM; Tabibian E; Alidoosti A; Rahimifar P; Akhavan S; Gandomkar Z
Cancer Imaging; 2019 Apr; 19(1):20. PubMed ID: 30935419
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Algorithm to Differentiate Benign Atypical Leiomyomas from Malignant Uterine Sarcomas with Diffusion-weighted MRI.
Abdel Wahab C; Jannot AS; Bonaffini PA; Bourillon C; Cornou C; Lefrère-Belda MA; Bats AS; Thomassin-Naggara I; Bellucci A; Reinhold C; Fournier LS
Radiology; 2020 Nov; 297(2):361-371. PubMed ID: 32930650
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of 3 T MR spectroscopy, diffusion-weighted MRI, and apparent diffusion coefficient value for distinguishing benign from malignant myometrial tumours.
Rahimifar P; Hashemi H; Malek M; Ebrahimi S; Tabibian E; Alidoosti A; Mousavi A; Yarandi F
Clin Radiol; 2019 Jul; 74(7):571.e9-571.e18. PubMed ID: 31010584
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the diagnostic accuracy of contrast-enhanced MRI and diffusion-weighted MRI in the differentiation between uterine leiomyosarcoma / smooth muscle tumor with uncertain malignant potential and benign leiomyoma.
Lin G; Yang LY; Huang YT; Ng KK; Ng SH; Ueng SH; Chao A; Yen TC; Chang TC; Lai CH
J Magn Reson Imaging; 2016 Feb; 43(2):333-42. PubMed ID: 26383110
[TBL] [Abstract][Full Text] [Related]
6. Smooth muscle tumours of the uterus: MR imaging malignant predictive features-a 12-year analysis in a referral hospital in Portugal.
Freitas P; Resende-Neves T; Lameira P; Costa M; Dias P; Filipe J; Ferreira J; Félix A; Cunha TM
Arch Gynecol Obstet; 2024 Apr; 309(4):1551-1560. PubMed ID: 38055011
[TBL] [Abstract][Full Text] [Related]
7. T2 hyperintense myometrial tumors: can MRI features differentiate leiomyomas from leiomyosarcomas?
Rio G; Lima M; Gil R; Horta M; Cunha TM
Abdom Radiol (NY); 2019 Oct; 44(10):3388-3397. PubMed ID: 31250178
[TBL] [Abstract][Full Text] [Related]
8. Diffusion MRI of uterine and ovarian masses: identifying the benign lesions.
Davarpanah AH; Kambadakone A; Holalkere NS; Guimaraes AR; Hahn PF; Lee SI
Abdom Radiol (NY); 2016 Dec; 41(12):2466-2475. PubMed ID: 27660280
[TBL] [Abstract][Full Text] [Related]
9. A machine learning approach for distinguishing uterine sarcoma from leiomyomas based on perfusion weighted MRI parameters.
Malek M; Gity M; Alidoosti A; Oghabian Z; Rahimifar P; Seyed Ebrahimi SM; Tabibian E; Oghabian MA
Eur J Radiol; 2019 Jan; 110():203-211. PubMed ID: 30599861
[TBL] [Abstract][Full Text] [Related]
10. Utility of magnetic resonance imaging for differentiating malignant mesenchymal tumors of the uterus from T2-weighted hyperintense leiomyomas.
Matsuura K; Inoue K; Hoshino E; Yasuda M; Hasegawa K; Okada Y; Baba Y; Kozawa E
Jpn J Radiol; 2022 Apr; 40(4):385-395. PubMed ID: 34750737
[TBL] [Abstract][Full Text] [Related]
11. Combined use of T2-weighted and diffusion-weighted 3-T MR imaging for differentiating uterine sarcomas from benign leiomyomas.
Namimoto T; Yamashita Y; Awai K; Nakaura T; Yanaga Y; Hirai T; Saito T; Katabuchi H
Eur Radiol; 2009 Nov; 19(11):2756-64. PubMed ID: 19504102
[TBL] [Abstract][Full Text] [Related]
12. How to differentiate benign from malignant myometrial tumours using MR imaging.
Thomassin-Naggara I; Dechoux S; Bonneau C; Morel A; Rouzier R; Carette MF; Daraï E; Bazot M
Eur Radiol; 2013 Aug; 23(8):2306-14. PubMed ID: 23563602
[TBL] [Abstract][Full Text] [Related]
13. Uterine mesenchymal tumors: development and preliminary results of a magnetic resonance imaging (MRI) diagnostic algorithm.
Rosa F; Martinetti C; Magnaldi S; Rizzo S; Manganaro L; Migone S; Ardoino S; Schettini D; Marchiolè P; Ragusa T; Gandolfo N
Radiol Med; 2023 Jul; 128(7):853-868. PubMed ID: 37311925
[TBL] [Abstract][Full Text] [Related]
14. Explorative Investigation of Whole-Lesion Histogram MRI Metrics for Differentiating Uterine Leiomyomas and Leiomyosarcomas.
Gerges L; Popiolek D; Rosenkrantz AB
AJR Am J Roentgenol; 2018 May; 210(5):1172-1177. PubMed ID: 29547053
[TBL] [Abstract][Full Text] [Related]
15. Assessment of MR Imaging as a Tool to Differentiate between the Major Histological Types of Uterine Sarcomas.
Sumi A; Terasaki H; Sanada S; Uchida M; Tomioka Y; Kamura T; Yano H; Abe T
Magn Reson Med Sci; 2015; 14(4):295-304. PubMed ID: 26104072
[TBL] [Abstract][Full Text] [Related]
16. Value of ultrasonography and magnetic resonance imaging for the characterization of uterine mesenchymal tumors.
Bonneau C; Thomassin-Naggara I; Dechoux S; Cortez A; Darai E; Rouzier R
Acta Obstet Gynecol Scand; 2014 Mar; 93(3):261-8. PubMed ID: 24372487
[TBL] [Abstract][Full Text] [Related]
17. The role of multiparametric MRI in differentiating uterine leiomyosarcoma from benign degenerative leiomyoma and leiomyoma variants: a retrospective analysis.
Mahmood NS; Al Rashid AA; Ladumor SB; Mohamed MA; Kambal AS; Saloum N; Mohamed SEMK; Al Hyassat S; Singh R
Clin Radiol; 2023 Jan; 78(1):47-54. PubMed ID: 36220736
[TBL] [Abstract][Full Text] [Related]
18. Hyperintense uterine myometrial masses on T2-weighted magnetic resonance imaging: differentiation with diffusion-weighted magnetic resonance imaging.
Takeuchi M; Matsuzaki K; Nishitani H
J Comput Assist Tomogr; 2009; 33(6):834-7. PubMed ID: 19940646
[TBL] [Abstract][Full Text] [Related]
19. Uterine Artery Embolization of Uterine Leiomyomas: Predictive MRI Features of Volumetric Response.
Kurban LAS; Metwally H; Abdullah M; Kerban A; Oulhaj A; Alkoteesh JA
AJR Am J Roentgenol; 2021 Apr; 216(4):967-974. PubMed ID: 33594913
[No Abstract] [Full Text] [Related]
20. Utility of Clinical Parameters and Multiparametric MRI as Predictive Factors for Differentiating Uterine Sarcoma From Atypical Leiomyoma.
Bi Q; Xiao Z; Lv F; Liu Y; Zou C; Shen Y
Acad Radiol; 2018 Aug; 25(8):993-1002. PubMed ID: 29422425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
